Vitamin D mitigates ethanol preference in rats via the DRD2-GDNF and antioxidant signaling in vivo Vitamin D effect on ethanol CPP
Iranian Journal of Pharmaceutical Sciences,
Vol. 21 No. 1 (2025),
21 January 2025
,
Page 470-481
https://doi.org/10.22037/ijps.v21i1.49497
Abstract
Alcohol abuse is a widespread mental disorder with significant health complications. A relationship between vitamin D (VitD) and ethanol abuse has been established. VitD, as a vital element for the development and metabolism of dopaminergic neurons, affects dopamine and glial cell line-derived neurotrophic factor (GDNF) synthesis and may play a role in the pathogenesis of alcohol-related disorders. In this study, we aimed to examine the role of VitD in the attenuation of ethanol-induced conditioned place preference in rats via dopamine D2 receptor-GDNF and antioxidant signaling in vivo. Rats were randomly divided into control, ethanol (Eth), and three Eth+VitD groups for behavioral experiments in conditioned place preference (CPP) and an open field. The activities of different brain oxidants (MDA, NO, and TOS), as well as antioxidative parameters (CAT, GPx, SOD, and TAC), plus oxidative stress index (OSI) and plasma VitD levels, were measured. Finally, hippocampal NOX, GDNF, and DRD2 expression were examined by western blotting. VitD (500 IU) combined with the effective dose of Eth (1.25 g/kg) resulted in the maximum decrease in CPP with no effect on locomotion. VitD supplementation elevated plasma VitD levels post-conditioning, increased the activities of brain antioxidants, and overexpressed hippocampal NOX, GDNF, and DRD2 proteins. We demonstrate that VitD attenuates alcohol-induced conditioning in rats via DRD2-GDNF and antioxidant signaling in vivo. Hence, targeting GDNF signaling may be a novel approach for the development of new drugs to treat Eth-related disorders among VitD users.
- Alcohol conditioning
- CPP
- Dopamine
- GDNF
- in-vivo
- Vitamin D
How to Cite
References
American Psychiatric Association D, American Psychiatric Association D. Diagnostic and statistical manual of mental disorders: DSM-5: American psychiatric association Washington, DC; (2013).
2. Zahr NM, Pfefferbaum A. Alcohol’s effects on the brain: neuroimaging results in humans and animal models. Alcohol. Res. (2017) 38(2):183.
3. Nickovic VP, Miric D, Kisic B, Kocic H, Stojanovic M, Buttice S, et al. Oxidative stress, NOx/l-arginine ratio and glutathione/glutathione S-transferase ratio as predictors of ‘sterile inflammation’in patients with alcoholic cirrhosis and hepatorenal syndrome type II. Renal .Fail. (2018) 40(1):340-9.
4. Rao R, Seth A, Sheth P. Recent advances in alcoholic liver disease I. Role of intestinal permeability and endotoxemia in alcoholic liver disease. Am. J. Physiol. Gastrointest. Live.r Physiol. (2004) 286(6):G881-G4.
5. Cederbaum AI, Lu Y, Wu D. Role of oxidative stress in alcohol-induced liver injury. Arch. Toxicol. (2009) 83:519-48.
6. Banjac Baljak V, Mihajlovic G, Zivlak-Radulovic N, Nezic L, Miskovic M, Banjac V, editors. Association between Vitamin D and Cognitive Deficiency in Alcohol Dependence. Healthcare (Basel).(2022) MDPI.
7. Stulic M, Jadzic J, Dostanic N, Zivkovic M, Stojkovic T, Aleksic J, et al. Clinical Indicators of Bone Deterioration in Alcoholic Liver Cirrhosis and Chronic Alcohol Abuse: Looking beyond Bone Fracture Occurrence. . Diagn. (2024) 14(5):510.
8. Tardelli VS, do Lago MPP, da Silveira DX, Fidalgo TM. Vitamin D and alcohol: A review of the current literature. Psychiatry. Res. (2017) 248:83-6.
9. Mayne PE, Burne TH. Vitamin D in synaptic plasticity, cognitive function, and neuropsychiatric illness. Trends. Neurosci. (2019) 42(4):293-306.
10. Jiang P, Zhang L-H, Cai H-L, Li H-D, Liu Y-P, Tang M-M, et al. Neurochemical effects of chronic administration of calcitriol in rats. Nutrients. (2014) 6(12):6048-59.
11. Kaneko I, Sabir MS, Dussik CM, Whitfield GK, Karrys A, Hsieh JC, et al. 1, 25‐Dihydroxyvitamin D regulates expression of the tryptophan hydroxylase 2 and leptin genes: implication for behavioral influences of vitamin D. FASEB. J. (2015) 29(9):4023-35.
12. Kesby JP, Cui X, Ko P, McGrath JJ, Burne TH, Eyles DW. Developmental vitamin D deficiency alters dopamine turnover in neonatal rat forebrain. Neurosci. Lett. (2009) 461(2):155-8.
13. Pertile RA, Cui X, Eyles DW. Vitamin D signaling and the differentiation of developing dopamine systems. Neuroscience. (2016) 333:193-203.
14. Trinko JR, Land BB, Solecki WB, Wickham RJ, Tellez LA, Maldonado-Aviles J, et al. Vitamin D3: a role in dopamine circuit regulation, diet-induced obesity, and drug consumption. eNeuro. (2016) 3(3).
15. Kemény LV, Robinson KC, Hermann AL, Walker DM, Regan S, Yew YW, et al. Vitamin D deficiency exacerbates UV/endorphin and opioid addiction. Sci. Adv. (2021) 7(24):eabe4577.
16. Ortega-de San Luis C, Pascual A. Simultaneous detection of both GDNF and GFRα1 expression patterns in the mouse central nervous system. Front. Neuroanat. (2016) 10:73.
17. Pertile RA, Cui X, Hammond L, Eyles DW. Vitamin D regulation of GDNF/Ret signaling in dopaminergic neurons. FASEB. J. (2018) 32(2):819-28.
18. Barak S, Ahmadiantehrani S, Logrip ML, Ron D. GDNF and alcohol use disorder. Addict. Biol. (2019) 24(3):335-43.
19. Kumar A, Kopra J, Varendi K, Porokuokka LL, Panhelainen A, Kuure S, et al. GDNF overexpression from the native locus reveals its role in the nigrostriatal dopaminergic system function. PLoS .Genet. (2015) 11(12):e1005710.
20. Carnicella S, Ron D. GDNF—a potential target to treat addiction. Pharmacol. Ther. (2009) 122(1):9-18.
21. Ford MM, George BE, Van Laar VS, Holleran KM, Naidoo J, Hadaczek P, et al. GDNF gene therapy for alcohol use disorder in male non-human primates. Nat. Med. (2023) 29(8):2030-40.
22. Libarino-Santos M, Brandão NR, Borges ÁL, Anjos-Santos A, Cata-Preta EG, Barros-Santos T, et al. Aripiprazole and topiramate, alone or in combination, block the expression of ethanol-induced conditioned place preference in mice. Drug. Alcohol. Depend. (2021) 220:108520.
23. Oppong-Damoah A, Curry KE, Blough BE, Rice KC, Murnane KS. Effects of the synthetic psychedelic 2, 5-dimethoxy-4-iodoamphetamine (DOI) on ethanol consumption and place conditioning in male mice. Psychopharmacology. (2019) 236:3567-78.
24. Rezaeiasl Z, Nazari-Alam A, Kheiripour N, Salami M, Ardjmand A, Ghavipanjeh G. The Effect of Probiotic Supplementation on Morphine Preference in Rats: Possible Antioxidative/Oxidative Signaling Pathway. Jundishapur. J .Nat .Pharm. Prod. (2024) 19(3).
25. Saeedfar M, Ardjmand A, Alani B, Ghaderi A, Banafshe HR, Shahaboddin ME, et al. The effect of vitamin D on morphine preference in rats: Possible biochemical and DRD2–GDNF signaling. Brain. Behav. (2023) 13(2):e2877.
26. Chen M, Zhang X, Hao W. H3K4 dimethylation at FosB promoter in the striatum of chronic stressed rats promotes morphine-induced conditioned place preference. PLoS. ONE. (2019) 14(8):e0221506.
27. Mutlu M, Simsek UG, Iflazoglu S, Yilmaz A, Karabulut B, Incili CA, et al. Potential effect dietary supplementation of calcium tetraborate in quails exposed to cadmium: Its impact on productive performance, oxidative stress, cecal microflora, and histopathological changes. Ecotoxicol. Environ. Saf. (2024) 270:115883.
28. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. (1976) 72(1-2):248-54.
29. Campos-Jurado Y, Martí-Prats L, Morón JA, Polache A, Granero L, Hipólito L. Dose-dependent induction of CPP or CPA by intra-pVTA ethanol: Role of mu opioid receptors and effects on NMDA receptors. Prog. Neuro-Psychopharmacol. Biol. Psychiatry. (2020) 100:109875.
30. Eaton SE, Dzhala S, Robinson LE, Radevski ME, Akins CK. Ethanol induces a dose-dependent conditioned place preference and conditioned place aversion in Japanese quail. Exp. Clin. Psychopharmacol. (2023) 31(1):1.
31. Sanchez B, Relova JL, Gallego R, Ben‐Batalla I, Perez‐Fernandez R. 1, 25‐Dihydroxyvitamin D3 administration to 6‐hydroxydopamine‐lesioned rats increases glial cell line‐derived neurotrophic factor and partially restores tyrosine hydroxylase expression in substantia nigra and striatum. J. Neurosci. Res. (2009) 87(3):723-32.
32. Sedaghat K, Yousefian Z, Vafaei AA, Rashidy-Pour A, Parsaei H, Khaleghian A, et al. Mesolimbic dopamine system and its modulation by vitamin D in a chronic mild stress model of depression in the rat. Behav. Brain. Res. (2019) 356:156-69.
33. Eserian JK. Vitamin D as an effective treatment approach for drug abuse and addiction. J .Med .Hypo. Ideas. (2013) 7(2):35-9.
34. Moretti R, Morelli ME, Caruso P. Vitamin D in neurological diseases: a rationale for a pathogenic impact. . Int. J. Mol. Sci. (2018) 19(8):2245.
35. Orme RP, Bhangal MS, Fricker RA. Calcitriol imparts neuroprotection in vitro to midbrain dopaminergic neurons by upregulating GDNF expression. PLoS ONE. (2013) 8(4):e62040.
36. Yunusoğlu O. Rewarding effect of ethanol-induced conditioned place preference in mice: Effect of the monoterpenoid linalool. Alcohol. (2022) 98:55-63.
37. Novier A, Van Skike CE, Chin VS, Diaz-Granados JL, Matthews DB. Low and moderate doses of acute ethanol do not impair spatial cognition but facilitate accelerating rotarod performance in adolescent and adult rats. Neurosci. Lett. (2012) 512(1):38-42.
38. Van Skike CE, Botta P, Chin VS, Tokunaga S, McDaniel JM, Venard J, et al. Behavioral effects of ethanol in cerebellum are age dependent: potential system and molecular mechanisms. Alcohol. Clin. Exp. Res. (2010) 34(12):2070-80.
39. Chen L-J, Sha S, Stocker H, Brenner H, Schöttker B. The associations of serum vitamin D status and vitamin D supplements use with all-cause dementia, Alzheimer’s disease, and vascular dementia: a UK Biobank based prospective cohort study. Am. J. Clin. Nutr. (2024) 119(4):1052-64.
40. Basarslan S, Osun A, Senol S, Korkmaz M, Ozkan U, Kaplan I. Protective effects of intralipid and caffeic acid phenyl esther (CAPE) on neurotoxicity induced by ethanol in rats. Turk. Neurosurg. (2017) 27(1).
41. Cikler-Dulger E, Sogut I. Investigation of the protective effects of boric acid on ethanol induced kidney injury. Biotech. Histochem. (2020) 95(3):186-93.
42. Sogut I, Oglakci A, Kartkaya K, Ol KK, Sogut MS, Kanbak G, et al. Effect of boric acid on oxidative stress in rats with fetal alcohol syndrome. Exp. Ther. Med. (2015) 9(3):1023-7.
43. Sogut I, Paltun SO, Tuncdemir M, Ersoz M, Hurdag C. The antioxidant and antiapoptotic effect of boric acid on hepatoxicity in chronic alcohol-fed rats. Can. J. Physiol. Pharmacol. (2018) 96(4):404-11.
44. Huang Y, Flentke GR, Rivera OC, Saini N, Mooney SM, Smith SM. Alcohol Exposure Induces Nucleolar Stress and Apoptosis in Mouse Neural Stem Cells and Late-Term Fetal Brain. Cells. (2024) 13(5):440.
45. Ibi M, Sawada H, Nakanishi M, Kume T, Katsuki H, Kaneko S, et al. Protective effects of 1α, 25-(OH) 2D3 against the neurotoxicity of glutamate and reactive oxygen species in mesencephalic culture. Neuropharmacology.( 2001) 40(6):761-71.
46. Garcion E, Sindji L, Montero‐Menei C, Andre C, Brachet P, Darcy F. Expression of inducible nitric oxide synthase during rat brain inflammation: regulation by 1, 25‐dihydroxyvitamin D3. GLIA. (1998) 22(3):282-94.
47. Kimura T, Rahmani R, Miyamoto T, Kamio Y, Kudo D, Sato H, et al. Vitamin D deficiency promotes intracranial aneurysm rupture. J .Cereb. Blood. Flow. Metab. (2024) 0271678X241226750.
48. Lu Y, George J. Interaction between fatty acid oxidation and ethanol metabolism in liver. Am. J. Physiol. Gastrointest. Liver. Physiol. (2024) 326(5):G483-G94.
49. Zhang J-L, Guo Y-X, Suo M, Wong M-S, Poon CC-W, Peng W-F, et al. Regulation of vitamin D on mitochondria contributes to its therapeutic effects on kidney diseases: a mini-review. Precis. Nutr. (2024) 3(1):e00061.
50. Sönmez MB, Görgülü Y, Köse Çınar R, Kahyacı Kılıç E, Ünal A, Vardar ME. Alterations of BDNF and GDNF serum levels in alcohol-addicted patients during alcohol withdrawal. Eur. J .Psychiatry. (2016) 30(2):109-18.
51. Liran M, Rahamim N, Ron D, Barak S. Growth factors and alcohol use disorder. Cold. Spring. Harbor. Perspect. Med. (2020) 10(12):a039271.
52. Koskela M, Piepponen TP, Lindahl M, Harvey BK, Andressoo J-O, Võikar V, et al. The overexpression of GDNF in nucleus accumbens suppresses alcohol-seeking behavior in group-housed C57Bl/6J female mice. J. Biomed. Sci. (2021) 28:1-17.
53. Heberlein A, Muschler M, Wilhelm J, Frieling H, Lenz B, Gröschl M, et al. BDNF and GDNF serum levels in alcohol-dependent patients during withdrawal. Progress in Neuro-Psychopharmacology and Biological Psychiatry. (2010) 34(6):1060-4.
54. Lhullier AC, Moreira FP, da Silva RA, Marques MB, Bittencourt G, Pinheiro RT, et al. Increased serum neurotrophin levels related to alcohol use disorder in a young population sample. Alcohol. Clin. Exp. Res. (2015) 39(1):30-5.
55. Puchacz E, Stumpf WE, Stachowiak EK, Stachowiak MK. Vitamin D increases expression of the tyrosine hydroxylase gene in adrenal medullary cells. MOL. BRAIN. RES. (1996) 36(1):193-6.
56. Ericson M, Ulenius L, Andrén A, Jonsson S, Adermark L, Söderpalm B. Different dopamine tone in ethanol high‐and low‐consuming Wistar rats. Addict Biol. (2020) 25(3):e12761.
57. Kaagman DG, van Wegen EE, Cignetti N, Rothermel E, Vanbellingen T, Hirsch MA. Effects and Mechanisms of Exercise on Brain-Derived Neurotrophic Factor (BDNF) Levels and Clinical Outcomes in People with Parkinson’s Disease: A Systematic Review and Meta-Analysis. Brain. Sci. (2024) 14(3):194.
58. Li H-H, Wang X-F, Wang B, Jia F-Y. Vitamin D3 improves iminodipropionitrile-induced tic-like behavior in rats through regulation of GDNF/c-Ret signaling activity. Eur. Child. Adolesc. Psychiatry. (2024) 1-13.
59. Liu Y, Zhou X, Xue K, Sun R, Tang Y, Tang C. Reviving: restoring depression-like behaviour through glial cell–derived neurotrophic factor treatment in the medial prefrontal cortex. J. Psychiatry. Neurosci. (2024) 49(1):E23-E34.
60. Zhang XL, Sun Q, Quan ZS, Wu L, Liu ZM, Xia YQ, et al. Dopamine regulates colonic glial cell‐derived neurotrophic factor secretion through cholinergic dependent and independent pathways. Br. J. Pharmacol. (2024) 181(3):413-28.
61. Bono F, Savoia P, Guglielmi A, Gennarelli M, Piovani G, Sigala S, et al. Role of dopamine D2/D3 receptors in development, plasticity, and neuroprotection in human iPSC-derived midbrain dopaminergic neurons. Mol. Neurobiol. (2018) 55:1054-67.
62. Ahmadiantehrani S. Glial cell line-derived neurotrophic factor is a novel alcohol-responsive gene: Implications for the treatment of alcohol addiction: UCSF. ( 2012).
63. Barroso-Chinea P, Cruz-Muros I, Afonso-Oramas D, Castro-Hernández J, Salas-Hernández J, Chtarto A, et al. Long-term controlled GDNF over-expression reduces dopamine transporter activity without affecting tyrosine hydroxylase expression in the rat mesostriatal system. Neurobiol. Dis. (2016) 88:44-54.
64. Kozlov AV, Biagini G, Tomasi A, Zini I. Ex vivo demonstration of nitric oxide in the rat brain: effects of intrastriatal endothelin-1 injection. Neurosci. Lett. (1995) 196(1-2):140-4.
- Abstract Viewed: 150 times
- IJPS_Volume21_Issue1_Pages470-481 Downloaded: 110 times